Esterification of Docosahexaenoic Acid Enhances Its Transport to the Brain and Its Potential Therapeutic Use in Brain Diseases
Docosahexaenoic acid-containing lysophosphatidylcholine (DHA-LysoPC) is presented as the main transporter of DHA from blood plasma to the brain. This is related to the major facilitator superfamily domain-containing protein 2A (Mfsd2a) symporter expression in the blood–brain barrier that recognizes...
Main Authors: | Amanda Lo Van, Nathalie Bernoud-Hubac, Michel Lagarde |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/14/21/4550 |
Similar Items
-
Emerging Role of Phospholipids and Lysophospholipids for Improving Brain Docosahexaenoic Acid as Potential Preventive and Therapeutic Strategies for Neurological Diseases
by: Mayssa Hachem, et al.
Published: (2022-04-01) -
Specific uptake of DHA by the brain from a structured phospholipid, AceDoPC®
by: Bernoud-Hubac Nathalie, et al.
Published: (2017-03-01) -
AceDoPC, a structured phospholipid to target the brain with docosahexaenoic acid
by: Lagarde Michel, et al.
Published: (2016-01-01) -
Toxic effects of formaldehyde and the protective effect of docosahexaenoic acid in Drosophila
by: Hua Yanli, et al.
Published: (2021-10-01) -
Alcohol abuse and docosahexaenoic acid: Effects on cerebral circulation and neurosurvival
by: Michael A Collins
Published: (2015-01-01)